Sixth Street Partners Management Company »

Fennec Pharmaceuticals shares owned by Sixth Street Partners Management Company

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Sixth Street Partners Management Company from 13F filings

Historical chart of Sixth Street Partners Management Company investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Sixth Street Partners Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Sixth Street Partners Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $758k 71k 10.75

More positions owned by Sixth Street Partners Management Company

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Sixth Street Partners Management Company

Top funds holding Fennec Pharmaceuticals

Rosalind Advisors
AIGH Capital Management
Solas Capital Management
BlackRock
AWM Investment Company
Vanguard Capital Management
Prospect Capital Advisors
Geode Capital Management
State Street Corporation
Jane Street
Potomac Capital Management
Morgan Stanley
Vanguard Portfolio Management
Northern Trust
Marshall Wace

View all funds holding Fennec Pharmaceuticals